| Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | 2008/09/11 | English | 2,408 |
| Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | 2009/03/05 | English | 2,381 |
| Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms | 2004/08/01 | English | 2,360 |
| Tumour-educated macrophages promote tumour progression and metastasis | 2004/01/01 | English | 2,322 |
| Live or let die: the cell's response to p53 | 2002/08/01 | English | 2,320 |
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | 2007/05/17 | English | 2,306 |
| ERBB receptors and cancer: the complexity of targeted inhibitors | 2005/05/01 | English | 2,285 |
| Targeting hypoxia in cancer therapy | 2011/05/24 | English | 2,261 |
| Tumorigenesis and the angiogenic switch | 2003/06/01 | English | 2,248 |
| Tumour-cell invasion and migration: diversity and escape mechanisms | 2003/05/01 | English | 2,222 |
| Targeting RAS signalling pathways in cancer therapy | 2003/01/01 | English | 2,191 |
| Epidermal growth factor receptor mutations in lung cancer | 2007/03/01 | English | 2,167 |
| A census of human cancer genes | 2004/03/01 | English | 2,160 |
| Otto Warburg's contributions to current concepts of cancer metabolism | 2011/04/14 | English | 2,130 |
| Modes of resistance to anti-angiogenic therapy | 2008/08/01 | English | 2,039 |
| Exploiting tumour hypoxia in cancer treatment | 2004/06/01 | English | 2,018 |
| Photodynamic therapy and anti-tumour immunity | 2006/07/01 | English | 1,981 |
| Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis | 2007/10/01 | English | 1,967 |
| Cell-free nucleic acids as biomarkers in cancer patients | 2011/05/12 | English | 1,967 |
| Drug penetration in solid tumours | 2006/08/01 | English | 1,962 |
| Metastasis to bone: causes, consequences and therapeutic opportunities | 2002/08/01 | English | 1,898 |
| p21 in cancer: intricate networks and multiple activities | 2009/05/14 | English | 1,885 |
| Cancer chemoprevention with dietary phytochemicals | 2003/12/01 | English | 1,883 |
| Glycosylation in cancer: mechanisms and clinical implications | 2015/08/20 | English | 1,858 |
| Targeting cancer with small molecule kinase inhibitors | 2009/01/01 | English | 1,852 |
| A decade of exploring the cancer epigenome — biological and translational implications | 2011/09/23 | English | 1,849 |
| Fibroblast growth factor signalling: from development to cancer | 2010/02/01 | English | 1,836 |
| The NCI60 human tumour cell line anticancer drug screen | 2006/10/01 | English | 1,815 |
| NF-κB in cancer: from innocent bystander to major culprit | 2002/04/01 | English | 1,811 |
| Metastasis: from dissemination to organ-specific colonization | 2009/04/01 | English | 1,808 |